Nuklearmedicinsk diagnostik og cancerpræcisionsmedicin

Research output: Contribution to journalJournal articleResearchpeer-review

Annika Loft, Andreas Kjær

Cancer therapy has taken a major leap forward in recent years. However, to fully unfold the concept of precision medicine, non-invasive methods for characterisation of tumours and metastases are needed. PET imaging offers this. Whereas 18F-fluorodeoxyglucose-PET is currently used in most cancer types for diagnosing or staging, we expect new tracers to become available in the clinical routine, supporting tailoring and monitoring of cancer therapies.

Original languageDanish
Article numberV06180463
JournalUgeskrift for Laeger
Issue number46
Number of pages4
Publication statusPublished - 2018

ID: 219536574